发明名称 C-MET MODULATOR AND METHOD OF USE
摘要 <P>PROBLEM TO BE SOLVED: To provide compounds for modulating protein kinase enzymatic activity. <P>SOLUTION: The compounds for modulating protein kinase enzymatic activity for modulating cellular activity such as proliferation, differentiation, programmed cell death, migration and chemoinvasion are provided. More specifically, the compounds are quinazolines and quinolines which inhibit, regulate and/or modulate kinase receptor, particularly c-Met, KDR, c-Kit, flt-3 and flt-4, signal transduction pathways related to the changes in the cellular activity as the above. Compositions which contain these compounds and methods of using them to treat kinase-dependent diseases and conditions are also provided. Methods for producing the compounds and the compositions which contain these compounds are also provided. <P>COPYRIGHT: (C)2011,JPO&INPIT
申请公布号 JP2010235632(A) 申请公布日期 2010.10.21
申请号 JP20100158336 申请日期 2010.07.12
申请人 EXELIXIS INC 发明人 BANNEN LYNNE CANNE;CHAN DIVA SZE-MING;CHEN JEFF;DALRYMPLE LISA ESTHER;FORSYTH TIMOTHY PATRICK;HUYNH TAI PHAT;JAMMALAMADAKA VASU;KHOURY RICHARD GEORGE;LEAHY JAMES WILLIAM;MAC MORRISON B;MANN GRACE;MANN LARRY W;NUSS JOHN M;PARKS JASON JEVIOUS;TAKEUCHI CRAIG STACY;WANG YONG;ZHU WEI
分类号 C07D215/22;A61K;A61K31/47;A61K31/535;A61K31/5377;A61P1/00;A61P9/00;A61P9/10;A61P17/06;A61P19/02;A61P25/00;A61P27/02;A61P29/00;A61P35/00;A61P35/02;A61P37/00;A61P37/06;A61P43/00;C07D215/16;C07D215/20;C07D413/00 主分类号 C07D215/22
代理机构 代理人
主权项
地址